- Specialization
Biotechnologyand 1 more specialization valuesLess
- Materials Science
- Business
- Scientific Research
- Market
- Manufacturing
- Ecosystem
- AI for science
- Customers
Enterprisesand 2 more customers valuesLess
- Governments
- Researchers
More details
- Organization type
- Commercial Company
- Ecosystem
- AI for science
- Business
- Scientific Research
- Specialization
- Biotechnology, Materials Science
- Market
- Manufacturing
- Customers
- Enterprises, Governments, Researchers
- Delivery models
- Not classified
- Revenue models
- Licensing, Grants
- Listing status
- Not classified
- Latest equity round
- Not classified
- Reported funding amount
- Not classified
About
Birch Biosciences develops enzyme-based plastic recycling technologies, initially focused on PET and polyurethane plastics, for businesses, government agencies, and universities. Its differentiation is the combination of generative AI, machine learning, proprietary high-throughput screening, and engineered enzymes that break polymers into reusable chemical building blocks for circular recycling.
Market
Birch competes in biological and enzymatic plastic recycling within the broader circular-economy and climate-technology market, with current focus on PET and polyurethane waste. Its AI-native positioning combines generative AI and machine-learning-enabled enzyme engineering with proprietary high-throughput screening to break polymers into reusable monomers and produce 100% recycled resin. Relative to named competitors, Birch emphasizes low-temperature processing, a claimed reduction of more than 70% in recycling-related carbon emissions, virgin-equivalent resin quality, and economics at or below mechanical recycling, although its end-to-end process remains under development.
Birch's best-fit customers are B2B organizations in the plastics value chain, including packaging and beverage companies, polyester-textile manufacturers, polyurethane users in furniture, bedding, and insulation, recyclers, and sustainability-oriented consumer brands seeking circular, high-quality recycled resin. The likely buyer is an industrial R&D, materials, sustainability, or circularity leader at a medium-to-large company; this company-size and buyer-persona assessment is inferred from the industrial applications rather than explicitly stated by Birch.
At a Glance
Problem
Birch Biosciences addresses the limited circularity and poor economics of conventional plastic recycling. Much plastic still depends on oil- and gas-based virgin feedstocks, while recycling technologies face persistent challenges in energy efficiency and cost competitiveness. The environmental pain is landfill waste and continued fossil-feedstock use; the economic pain is the difficulty of producing recycled material cheaply enough and at sufficiently high quality to replace virgin plastic.
The clearest use case is polyethylene terephthalate (PET), used in beverage bottles, packaging, and polyester clothing. Birch aims to make it possible to take those waste streams back to their chemical building blocks and use them to manufacture the same high-value plastic products, rather than losing value through limited or non-circular recycling. Polyurethane products such as furniture, bedding, and insulation are a secondary target.
Product / Service
Birch is developing an industrial enzymatic recycling platform rather than a consumer product. Its generative-AI and machine-learning systems, combined with proprietary high-throughput screening, are used to design and optimize enzymes that act as molecular scissors. At relatively low temperatures, those enzymes break plastic polymers into monomers, which can then be re-polymerized into high-quality recycled plastic.
The intended delivery model appears to be deployment of the enzyme-enabled process in commercial recycling operations, supported by intellectual-property licensing and plant-scale implementation. Birch has licensed NREL technology for commercial PET deconstruction and says its process can enable economical, 100% recycled-content plastics while reducing carbon emissions by 70%; those performance claims are company-reported. Its roadmap calls for commercial-plant engineering and commercial-scale validation in 2027–2028, indicating that the product is still moving from technology development toward industrial deployment.
Market
Birch competes in advanced plastic recycling, particularly biological or enzymatic PET and polyester recycling, with an adjacent focus on polyurethane. The competitive set includes Carbios, which is developing enzymatic PET recycling; Protein Evolution, which uses enzymes to recycle polyester textile scrap; Samsara Eco, which uses AI-crafted enzymes to return plastics and textiles to monomers; and Epoch Biodesign, which applies AI-driven synthetic biology and enzymatic processes to recycle plastics and textiles, initially focusing on nylon. These companies overlap technologically, although they do not all target the same polymers or process configuration.
Birch’s visible traction is primarily technical and institutional rather than commercial sales traction. The company was founded in 2021, entered Y Combinator’s Summer 2022 batch, and is listed as an active Portland company with a 10-person team. It has reported DOE and NSF SBIR support, including a $1 million NSF Phase II award, a DARPA Biological Technologies Office award, an Agile BioFoundry collaboration, and the 2025 global NREL patent license. The available evidence supports classifying Birch as pre-commercial and likely pre-revenue: its sources describe grants, technology development, and a future commercial-plant roadmap, but do not establish recurring product revenue or an operating commercial plant.
Founders & Leadership
Funding History
OSTI
OSTI
Y Combinator
National Science Foundation
Recent News
Birch Biosciences announced it was awarded a $1.5 million U.S. Department of Energy SBIR Phase II grant for enzymatic polyurethane recycling. The company said the funding will support scaling enzyme production, optimizing the breakdown process, and refining the technology for large-scale applications.
Carpet America Recovery Effort awarded Birch Biosciences $50,000 to advance enzymatic recycling technology that converts post-consumer polyester carpet face fiber into virgin material.
Birch Biosciences entered a global patent license agreement with the National Renewable Energy Laboratory to commercialize enzymatic plastic-recycling technology.
Elevate Capital reported that Birch Biosciences secured a global patent license agreement with NREL and recognized Birch with its Best CleanTech Pitch Award for work using generative AI and advanced enzyme engineering.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Birch operates as a B2B deep-tech commercialization company, partnering with businesses, government agencies, and universities to develop and commercialize enzyme-based recycling technologies and licensed intellectual property. Public evidence also shows government R&D grants, while specific customer pricing, licensing terms, and recurring-revenue details are not disclosed.